Futile medication use in terminally ill cancer patients
- 742 Downloads
Cancer patients usually take many medications. The proportion of patients with advanced cancer who are taking futile drugs is unknown.
Materials and methods
We retrospectively reviewed the charts of all consecutive ambulatory patients with advanced cancer and who were receiving supportive care exclusively at palliative care clinics, Princess Margaret Hospital, to gather information on futile medications used by them. Futile medications were defined as unnecessary (when no short-term benefit to patients with respect to survival, quality of life, or symptom control was anticipated) or duplicate (two or more drugs from the same pharmacological class). Summary statistics were used to describe the results.
From November 2005 to July 2006, 82 (22%) of 372 patients were taking at least one futile medication before consultation; after initial consultation, this proportion dropped to 20% (78): 70 patients were taking unnecessary medications, while eight were on duplicate medications. The most frequent unnecessary medications used by patients were statins (56%). The most common duplicate medication involved the use of two different benzodiazepines (seven patients).
About one fifth of cancer outpatients at the end of life take futile medications, most commonly statins. Prospective and population-based studies are warranted to further evaluate the magnitude and consequences of futile medication use in oncology.
KeywordsCancer Drug therapy Medical futility
- 12.Nicholson A, Andrew I, Etherington R, et al (2001) Futile and inappropriate prescribing: an assessment of the issue in a series of patients admitted to a palliative care unit. Available at http://www.pharmj.com/IJPP/bpc2001/ijpp_bpc2001_r72.pdf
- 16.Zimmermann C, Walsh A, Gagliese L et al (2007) Determinants of referral of cancer patients to specialized palliative care. Psychooncology 16:S57Google Scholar
- 24.Samano ES, Goldenstein PT, Ribeiro Lde M et al (2004) Praying correlates with higher quality of life: results from a survey on complementary/alternative medicine use among a group of Brazilian cancer patients. Sao Paulo Med J 122:60–63 doi: 10.1590/S1516-31802004000200005 PubMedCrossRefGoogle Scholar
- 26.Back A (2006) Patient–physician communication in oncology: what does the evidence show? Oncology (Williston Park) 20:67–74 (discussion 77–78, 83)Google Scholar